Using nanoparticle-coated electrodes to improve gene editing for brain-computer interfaces
Official title: Nanoparticle Coated Microelectrode Arrays for Electrochemically Controlled Gene Editing at the Electrode Site
Funded at University of Pittsburgh at Pittsburgh · NIH-11089529 · Data updated 2026-11-12
This study is looking at new ways to make tiny brain-computer devices work better for people with limb loss or sensory issues by using special coatings to keep them effective for a longer time and reduce any irritation from the body’s immune system.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | June 1, 2023 |
| Project end | May 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $87,540 |
| NIH project number | 5F32MH132145-03 |
| Project ID | NIH-11089529 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with amputations or sensory deficits who may benefit from advanced prosthetic devices or sensory restoration technologies.
✕Less likely to help
Patients who do not have limb loss or sensory impairments may not receive any benefit from this research.
What this research studies
This research focuses on developing microelectrode arrays (MEAs) that are coated with nanoparticles to enhance their performance in brain-computer interfaces. These devices aim to help patients with limb loss or sensory deficits by providing stable and effective stimulation to neurons over long periods. The study investigates how to prevent the degradation of these electrodes and reduce inflammation caused by the body’s immune response, which can hinder their functionality. By exploring gene editing techniques, the research seeks to modify the immune response to improve the longevity and effectiveness of these implants.
Why it matters
Potential benefit: If successful, this research could lead to more effective and long-lasting brain-computer interfaces that significantly improve the quality of life for patients with limb loss or sensory impairments.
How similar studies have gone: Previous research has shown promise in using gene therapy techniques to modify immune responses, indicating potential success for this novel approach.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Williams, Nathaniel P — University of Pittsburgh at Pittsburgh
- Study coordinator: Williams, Nathaniel P
Related research
Other NIH-funded projects on the same topics.
-
Elastomeric membranes for safer pelvic organ prolapse repair
A new 3D-printed elastomeric membrane made from polycarbonate urethane is being tested to replace stiff polypropylene meshes for pelvic organ prolapse in women, aiming to reduce complications.
-
Role of hyaluronan in egg development and ovarian reserve
This grant studies how the hyaluronan matrix in the ovary affects the aging of the female reproductive system and the pool of eggs available.
-
Regulatory switches that control imprinting in early human development
This grant studies how certain genes stay “one-copy” active in early development and what goes wrong in assisted reproduction, with a focus on imprinting disorders.
-
Identifying molecular signs of imprinting errors linked to fertility treatments
This grant studies how assisted reproductive technologies may cause imprinting errors in embryos and how these errors relate to certain birth conditions, with implications for families using infertility treatments.
-
Bioadhesive vaginal film for 7-day protection against HIV, HSV, and pregnancy
A vaginal film that slowly releases antibodies to prevent HIV, HSV, and unintended pregnancy for about a week from a single use.
-
Spermatogonial stem cell transplantation and culture in patients
Researchers are testing a way to transplant or grow sperm-producing cells back in boys and men who stored tissue before cancer treatment, to help them have biological children in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.